Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry

Spekhorst, Lotte S; Ariëns, Lieneke F M; van der Schaft, Jorien; Bakker, Daphne S; Kamsteeg, Marijke; Oosting, Albert J; de Ridder, Ilona; Sloeserwij, Annemiek; Romeijn, Geertruida L E; de Graaf, Marlies; Haeck, Inge; Thijs, Judith L; Schuttelaar, Marie L A; de Bruin-Weller, Marjolein S

doi:https://doi.org/10.1111/all.14324

Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry

DSpace/Manakin Repository

Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry

Spekhorst, Lotte S; Ariëns, Lieneke F M; van der Schaft, Jorien; Bakker, Daphne S; Kamsteeg, Marijke; Oosting, Albert J; de Ridder, Ilona; Sloeserwij, Annemiek; Romeijn, Geertruida L E; de Graaf, Marlies; Haeck, Inge; Thijs, Judith L; Schuttelaar, Marie L A; de Bruin-Weller, Marjolein S

(2020) Allergy, volume 75, issue 9, pp. 2376 - 2379

(Comment)

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Immunology and Allergy, Immunology, Research Support, Non-U.S. Gov't, Letter

DOI: https://doi.org/10.1111/all.14324

ISSN: 0105-4538

Publisher: Wiley-Blackwell

(Peer reviewed)